B2V771 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigj2qbz6lvdkgxifeh6ottzz3glzgc6aawhvwsgztkvy7qg6s5hue/metadata.json
IPFS of structure file: 
bafybeif7hvgsibls6o7kq4ahbvhop42zkmj6ktvk5rwofb34lfzi2nexgy/AF-B2V771-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x5881B09f2D8e743400698633641fc1cD2Ed2BE6F
First NFT owner address (bech32): 
genesis1tzqmp8ed3e6rgqrfscekg87pe5hd90n0e7l5st
Current NFT ID #166940 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166940
Accession (UniProt):
B2V771
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Sulfurihydrogenibium sp. (strain YO3AOP1)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2V771 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2V771|HEM1_SULSY Glutamyl-tRNA reductase OS=Sulfurihydrogenibium sp. (strain YO3AOP1) OX=436114 GN=hemA PE=3 SV=1 MVIFSTGFNYKTAPVEIREKLAITENNYGLILEKLNSIEDIYEICVISTCNRVELYGVSNDNIEKVKEEILRILSQYSTVPVNTLKDYLFFYTNKEAIRHIFRVSSSLDSMVIGEPQIVCQFKDSFTKAKEYKAVRHILTRLFDKALNVSKKIRTSTGISRRAVSISYAAVLLAKKIFGDLKDKNVLIIGAGEMAELAAKHLHSLNVKHIFVSNRTFEKAVELADKFSGSAIRFEKIQEFLPEADIIIVSTGAKEPILKKEDVKRAIKSRKDPLFIIDISVPRNVEESVNELEGVYLYNIDDLKQVVNSNLEERKIEAQRAEFIIDEEVEKFVKWLNALKVSPIISSVRDYADKLRQQQLEKLFKQMPYLNEKERETIDLAMRSLINKLLHRPTMYIKDKAAKEGNTEVVKIFEDMFSSKWDFRKKGKNLEEIEDIVREEQ